InvestorsHub Logo
Followers 80
Posts 24707
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 01/04/2017 9:03:28 AM

Wednesday, January 04, 2017 9:03:28 AM

Post# of 27625
APHB - .4851 Pre-market at .50/.52.

Renowned Sinus Surgeon Dr. Peter-John Wormald Comments on AmpliPhi Biosciences' Favorable Phase 1 Results of AB-SA01 in Chronic Rhinosinusitis Patients



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.